Skip to content
All days

A routine day

A landscape day, step by step

Search trials, narrow them, read why some stopped, check a product's approvals and patents, export a dated table and see later what changed.

Who it is for A business development or competitive intelligence analyst building a deck.

Step by step

  1. 1Pipeline

    Search the registered trials

    One search by condition, product, sponsor or target.

    KRAS G12D Clinical Trials: Selected Registry Landscape

    Limit ClinicalTrials.gov only, so trials registered only elsewhere are missing. A target search is a text search.

  2. 2Pipeline

    Narrow the trials

    Filter by phase, status, sponsor class and start year, or press a chart mark.

    Open in Pipeline

  3. 3Pipeline

    Read why trials stopped

    Reasons for stopping, grouped by keyword, each with an example as registered.

    Open in Pipeline

  4. 4Pipeline

    Read a product's US approvals and FDA precedent

    A product search lists its applications in Drugs@FDA, and the precedent view describes each one.

    FDA Complete Response Letters (CRL) and Approval Precedent

    Limit Review times and designations cover FDA's new molecular entity and new biologic approvals, April 1985 to December 2025. Other products show fewer facts. It describes past approvals and is not a forecast.

    Next, in Patent

  5. 5Patent

    Check the product's listed patents and exclusivities

    The application opens with a range of listed protection, each date traced to its FDA rule and row.

    Open in Patent

    Limit A range of listed dates, not a loss-of-exclusivity date. Litigation, settlements, unlisted patents, at-risk launches, authorised generics and term extensions are not in these files. A missing Paragraph IV row does not mean none was filed.

  6. 6Pipeline

    Export the deck table and the timeline

    One row per trial with its source and dates, and a timeline by phase.

    Open in Pipeline

  7. 7Pipeline

    Reopen the view later

    A saved view shows what changed since it was saved: trials added, updated or no longer returned.

    Open in Pipeline

What this day does not cover

  • Trial counts are not programme counts. Sponsors enter the records, and statuses lag.
  • The patent view is at an early stage, with an independent regulatory review pending.

For research and education only, and not medical, investment, regulatory or legal advice.